12 Stem Cell Therapy Clinics in Seattle, Washington

Washington cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in Washington for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. Washington licenses naturopathic physicians with broader injection scope than many states.

• Washington Medical Practice Act, RCW Chapter 18.71
  Establishes physician licensure and discipline through the Washington Medical Commission.
• Washington Naturopathy Act, RCW Chapter 18.36A
  Provides licensed naturopathic physicians with prescriptive and injection authority broader than most states; cellular biologics outside FDA authorization remain unlawful.
• Washington Consumer Protection Act, RCW Chapter 19.86
  Empowers the Attorney General and private plaintiffs to pursue deceptive marketing claims against providers making unsupported clinical claims.

The FDA has corresponded with Washington providers offering cellular therapies. The Washington Medical Commission has disciplined physicians for unprofessional conduct including misleading regenerative medicine advertising. The Washington Board of Naturopathy has disciplinary authority over NDs operating outside scope. The Washington Attorney General has used the Washington Consumer Protection Act to pursue providers making unsupported clinical claims, with treble damages available. Federal warning letters apply nationally.